Environmental Testing Standards
Apexbio Technology LLC Methyl tridecanoate 1731-88-0 10g
Methyl tridecanoate (CAS 1731-88-0) is a small-molecule inhibitor targeting -amyloid protein aggregation and acetylcholinesterase (AChE) It is designed to moderately inhibit -amyloid aggregation and weakly inhibit AChE activity Methyl tridecanoate exerts its biological activity primarily through inhibition of -amyloid aggregation and AChE enzymatic function [No experimental model/cell line or IC50/EC50 reported ]Based on these pharmacological properties methyl tridecanoate holds research potential in neurodegenerative disease models and lipid metabolism studies
Apexbio Technology LLC Metronidazole Benzoate 13182-89-3 10g
Metronidazole Benzoate (13182-89-3) is a small-molecule inhibitor targeting microbial DNA synthesis It is designed to inhibit nucleic acid synthesis processes thereby disrupting microbial cellular function Metronidazole Benzoate exerts its biological activity primarily through inhibition of nucleic acid synthesis and function within microbial cells In in vitro studies its efficacy is often quantified by IC50 values reflecting the concentration required to achieve half-maximal inhibition of microbial growth Based on these pharmacological properties Metronidazole Benzoate holds research potential in investigations of treatments for bacterial and protozoal infections
Apexbio Technology LLC Arbutin 497-76-7 10g
Arbutin (CAS 497-76-7) is a naturally occurring glycosylated hydroquinone primarily isolated from bearberry (Arctostaphylos uva-ursi) leaves It acts as a competitive inhibitor of tyrosinase an enzyme central to melanin biosynthesis thereby modulating pigment production in biological systems Arbutin is extensively studied in cellular and biochemical assays investigating melanogenesis oxidative stress and potential antimelanogenic therapies Its ability to regulate melanin synthesis has made it a valuable research tool in dermatology cosmetic science and pharmacological studies focused on hyperpigmentation and related disorders The compound should be stored in a sealed cool and dry environment to maintain stability
Apexbio Technology LLC Prilocaine hydrochloride 1786-81-8 10g
Prilocaine hydrochloride (CAS 1786-81-8) is a local anesthetic belonging to the amino amide class It functions by reversibly inhibiting voltage-gated sodium channels on neuronal cell membranes thereby blocking the initiation and propagation of nerve impulses This property makes it suitable for investigating neuronal excitability pain signaling and ion channel pharmacology in various preclinical models Prilocaine hydrochloride is commonly employed in studies requiring local anesthesia and serves as a reference compound for benchmarking novel anesthetic agents in research settings
Apexbio Technology LLC Bismuth Subsalicylate 14882-18-9 10g
Bismuth subsalicylate (CAS 14882-18-9) is a small molecule compound clinically employed in the management of gastrointestinal disturbances including diarrhea heartburn indigestion and nausea Its pharmacological activity involves a dual mechanism the bismuth component exerts antimicrobial and protective effects on the gastrointestinal mucosa while the salicylate moiety inhibits intestinal prostaglandin synthesis thereby reducing inflammation and intestinal secretions Bismuth subsalicylate is utilized in biomedical research to investigate gastrointestinal barrier function host microbe interactions and inflammatory pathways relevant to digestive disorders
Apexbio Technology LLC Diphenylpyraline HCl 132-18-3 10g
Diphenylpyraline HCl (CAS 132-18-3) is a small molecule classified within the diphenylpiperidine group and functions as a first-generation antihistamine It acts by competitively inhibiting histamine H1 receptors thereby attenuating histamine-mediated cellular responses In addition to its antihistaminic activity diphenylpyraline exhibits anticholinergic properties influencing neurotransmitter regulation within the central and peripheral nervous systems This compound is widely utilized in the study of histaminergic and cholinergic pathways as well as for elucidating mechanisms underlying allergic reactions and central nervous system disorders
Apexbio Technology LLC (-)-Tetramisole 16595-80-5 10g
(-)-Tetramisole is an immunomodulatory agent that stimulates nicotinic acetylcholine receptors leading to the activation of T-lymphocytes macrophages and phagocytic cells to enhance cell-mediated immune responses (-)-Tetramisole exerts its biological activity primarily through activation of nicotinic acetylcholine receptors Additionally it is utilized in the investigation of epigenetic regulation pathways involving lysine-specific demethylase 1 (LSD1) serving as a research tool to study chromatin modulation mechanisms and gene expression control Based on these pharmacological properties (-)-Tetramisole holds research potential in immunological signaling studies and tumor biology
Apexbio Technology LLC Docosanol (Abreua) 661-19-8 10g
Docosanol Abreua (CAS 661-19-8) is a small-molecule inhibitor targeting herpes simplex virus (HSV) It is designed to inhibit viral entry processes thereby preventing HSV replication at the initial stage of infection Docosanol Abreua exerts its biological activity primarily through the inhibition of viral envelope fusion with host cell membranes In cell-based studies Docosanol Abreua demonstrates antiviral inhibition with an IC50 value typically in the range of approximately 2 5-5 M Based on these pharmacological properties Docosanol Abreua holds research potential in antiviral mechanism studies investigation of viral entry pathways and host pathogen interaction assays
Apexbio Technology LLC Tioconazole 65899-73-2 10g
Tioconazole (65899-73-2) is a small-molecule inhibitor targeting the fungal cytochrome P450-dependent enzyme lanosterol 14 -demethylase It is designed to inhibit ergosterol biosynthesis thereby disrupting fungal cell membrane stability and cellular integrity Tioconazole exerts its biological activity primarily through interference with ergosterol biosynthesis within fungal cell membranes In in vitro studies Tioconazole demonstrates inhibitory activity with MIC50 values below 3 12 mg/L for dermatophyte strains and below 9 mg/L for yeast species Based on these pharmacological properties Tioconazole holds research potential in the study of antifungal mechanisms and in vitro antifungal screening assays
Apexbio Technology LLC Tolfenamic Acid 13710-19-5 10g
Tolfenamic acid (CAS 13710-19-5) is a non-steroidal anti-inflammatory drug (NSAID) that functions primarily through the inhibition of cyclooxygenase (COX) enzymes resulting in reduced prostaglandin synthesis and inflammation In cellular studies tolfenamic acid has been observed to inhibit cell proliferation and promote apoptosis as indicated by heightened caspase activity and alterations in bioelectric impedance measurements These findings support its utility in research investigating inflammatory pathways apoptosis induction and the cellular effects of NSAIDs in various biological systems
Apexbio Technology LLC Uniconazole 83657-22-1 10g
Uniconazole (CAS 83657-22-1) is a small-molecule inhibitor of cytochrome P450 707A enzymes (CYP707As) which are involved in the catabolism of abscisic acid (ABA) via 8 -hydroxylation In in vitro assays uniconazole demonstrated potent inhibition of CYP707A3 activity with a reported Ki of 68 nM surpassing other plant growth retardants such as paclobutrazol and tetcyclacis In Arabidopsis models uniconazole treatment elevated endogenous ABA levels and enhanced drought tolerance effects that were independent of gibberellin-mediated pathways Uniconazole is therefore utilized in plant biology research to study ABA metabolism and stress responses
Apexbio Technology LLC PTP Inhibitor I 2491-38-5 10g
PTP Inhibitor I (CAS 2491-38-5) is a small molecule inhibitor targeting protein tyrosine phosphatases (PTPs) specifically SHP-1 and PTP1B with inhibition constants (KI) of 43 M and 42 M respectively As an -bromoacetophenone derivative it acts as a neutral phosphotyrosine mimetic covalently modifying the active site cysteine of PTPs Structure-activity studies indicate that modifications to the phenyl ring moderately affect potency while para-substituted peptidyl groups can enhance both potency and selectivity PTP Inhibitor I is utilized in vitro for mechanistic studies of PTP function related to diabetes neurodegenerative disorders immune regulation and pathogen virulence Animal and clinical data are not available